文献速递腹部介入CTMR

人工智能模型预测肝细胞癌经动脉化疗栓塞治疗反应性的表现:系统综述与Meta分析

Performance of Artificial Intelligence Models in Predicting Responsiveness of Hepatocellular Carcinoma to Transarterial Chemoembolization (TACE): A Systematic Review and Meta-Analysis.
PubMed 文献 · J Am Coll Radiol · 2025-08-30

该系统综述与Meta分析检索4个数据库至2024年6月15日,纳入27项研究,其中11项研究纳入TACE治疗反应预测模型的总体Meta分析;汇总AUC内部验证为0.89、外部验证为0.81,二者无显著差异(P=.66),DL与HCR模型间(P=.21)及含与不含临床数据的模型间(P=.78)均无显著差异;作者认为AI模型显示预测潜力,但观察到的异质性强调需进一步研究。

要点

  • AI模型预测HCC患者TACE治疗反应的汇总AUC内部验证0.89、外部验证0.81,二者无显著差异(P=.66)。
  • DL模型与HCR模型间(P=.21)、含与不含临床数据的模型间(P=.78)预测表现均无显著差异。
  • 作者指出观察到的异质性强调需进一步研究。

核心结论

  • 人工智能模型(包括DL和HCR)在预测接受TACE的HCC患者治疗结局方面显示出潜力,但观察到的异质性强调需进一步研究。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase、Web of Science和Cochrane Library数据库至2024年6月15日,纳入27项研究,其中11项研究纳入TACE治疗反应预测模型的总体Meta分析;采用双变量模型进行随机效应诊断试验准确性Meta分析,并使用预测模型偏倚风险评估工具评价方法学质量。

诊断标准与关键数值

  • TACE治疗反应预测模型的汇总AUC:内部验证0.89(95%CI 0.81-0.93),外部验证0.81(95%CI 0.80-0.92),二者无显著差异(P=.66)。
  • DL模型与HCR模型间预测表现无显著差异(P=.21)。
  • 含临床数据与不含临床数据的模型间预测表现无显著差异(P=.78)。

临床应用与阅片要点

  • 作者认为人工智能模型(包括DL和HCR)在预测接受TACE的HCC患者治疗结局方面显示出潜力。

局限性

  • 作者指出观察到的异质性强调需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide. Handcrafted radiomics (HCR) and deep learning (DL) models have emerged as promising predictive tools extracting granular insights from images.

OBJECTIVE: This systematic review and meta-analysis aims to evaluate the predictive performance of these artificial intelligence models in predicting treatment efficacy in patients with HCC who are undergoing transarterial chemoembolization (TACE).

METHODS: A comprehensive search was conducted on PubMed, Embase, Web of Science, and Cochrane Library databases up to June 15, 2024. Inclusion criteria encompassed studies involving patients with confirmed HCC undergoing TACE. Random-effects diagnostic test accuracy meta-analyses were performed using bivariate modeling. Methodological quality was assessed using the Prediction model Risk of Bias Assessment Tool.

RESULTS: Twenty-seven studies were included in this review. The overall meta-analysis of models for TACE treatment response included 11 studies. The pooled area under the receiver operating characteristic curve was 0.89 (95% confidence interval: 0.81-0.93) for internal validation and 0.81 (95% confidence interval: 0.80-0.92) for external validation, with no significant differences (P = .66). Moreover, no significant differences were found between DL and HCR models (P = .21) or between models with and without clinical data (P = .78).

CONCLUSION: Artificial intelligence models, including DL and HCR, show potential for predicting treatment outcomes in patients with HCC who are undergoing TACE. However, the observed heterogeneity stresses the need for further research.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Kiani I, Razeghian I, Valizadeh P, et al. Performance of Artificial Intelligence Models in Predicting Responsiveness of Hepatocellular Carcinoma to Transarterial Chemoembolization (TACE): A Systematic Review and Meta-Analysis. J Am Coll Radiol. 2025. PMID: 40889566. doi:10.1016/j.jacr.2025.08.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。